<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "ipilimumab inj VIAL">
<dose><value>3</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>5 mg/mL</value>
</strength>
<frequency><value>EVERY 3 WEEKS</value>
</frequency>
<instruction><value>for 4 doses. Administer dose over 30 minutes through an in-line 0.2 to 0.22 micron filter. If patient has experienced a prior infusion reaction, adminster all subsequent infusions over 90 minutes.</value>
</instruction>
<volume><value>10 mL</value>
<value>40 mL</value>
</volume>
<units><value>mg/kg</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>If bilirubin is greater than 1.5 X upper limit normal or ALT or AST greater than 2.5 X upper limit normal: Hold treatment and contact prescriber. Doses are either delayed or discontinued for toxicity, doses are not reduced.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=7441</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions.</value>
</AHSFormularyStatus>
<AHFSName><value>Antineoplastic Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>